Genentech to onshore US manufacturing amid rising drug pricing tensions
As the administration pushes for a return to US manufacturing, outsourcing agreements with domestic manufacturers are increasing.
Drug Manufacturers
Can pharma tariffs “Make America Manufacture Again”?
Revamping US pharma manufacturing: Trump’s executive order faces industry doubts
Roche plans $700m manufacturing plant in the US
Thermo Fisher counters tariffs with $2bn investment into US manufacturing
3 reasons why biotechs preparing for launch need a compliant content foundation
Novartis commits $23bn to US manufacturing amid tariff threats
China’s NMPA authorises Santen’s glaucoma treatment application
